The effect of amycretin, a unimolecular glucagon-like peptide-1 and amylin receptor agonist, on body weight and metabolic dysfunction in mice and rats
Authors:
Rune E Kuhre1; Borja Ballarín-González2; Christian L Brand1; Tine Glendorf1; Kim Grimstrup Madsen1; Karina R Hjøllund1; Wouter FJ Hogendorf3; David H Ipsen1; Sofia Lundh1; Thomas Kruse3; Signe B Petersen1; Anna Secher1; Andreas Vegge4; Kirsten Raun1
Affiliations
View DetailsHide Details
{{ getPageNum(PDFPage) }}
Share
Copy link
{{pageUrl}}
Keywords
Obesity
Congress oral presentation
GLP-1 RA
Amycretin
Pre-clinical
Get notified when materials for EASD 2025 and future congresses become available:
Slide decks
Posters
Videos ... and more.
Get notified when materials for EASD 2025 and future congresses become available:
Slide decks
Posters
Videos ... and more.
{{ error.$message }}
Success
We will notify you when new materials become available for EASD 2025 and future congresses.
We will keep you updated in your inbox:
Subscribe to receive updates on related congresses in the same disease area: